Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-12-009118
Filing Date
2012-09-27
Accepted
2012-09-27 06:30:48
Documents
12
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 10-K a2211059z10-k.htm 10-K 888767
2 EX-10.67 a2211059zex-10_67.htm EX-10.67 187344
3 EX-23.1 a2211059zex-23_1.htm EX-23.1 2857
4 EX-31.1 a2211059zex-31_1.htm EX-31.1 8072
5 EX-31.2 a2211059zex-31_2.htm EX-31.2 8093
6 EX-32.1 a2211059zex-32_1.htm EX-32.1 5851
  Complete submission text file 0001047469-12-009118.txt   7025130

Data Files

Seq Description Document Type Size
7 EX-101.INS conx-20120630.xml EX-101.INS 654123
8 EX-101.SCH conx-20120630.xsd EX-101.SCH 57793
9 EX-101.CAL conx-20120630_cal.xml EX-101.CAL 90132
10 EX-101.LAB conx-20120630_lab.xml EX-101.LAB 1102644
11 EX-101.PRE conx-20120630_pre.xml EX-101.PRE 491676
12 EX-101.DEF conx-20120630_def.xml EX-101.DEF 339227
Mailing Address 120621 TEJON ST WESTMINSTER CO 80234
Business Address 12061 TEJON STREET 303-751-4831 WESTMINSTER CO 80234 3034574345
CORGENIX MEDICAL CORP/CO (Filer) CIK: 0001063665 (see all company filings)

EIN.: 931223466 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-24541 | Film No.: 121111863
SIC: 2835 In Vitro & In Vivo Diagnostic Substances